MAR 18, 2015 12:41 PM PDT

Tiny Diamonds--A Cancer Cell's Best Friend?

WRITTEN BY: Will Hector
Cancer stem cells often cause tumors to form and are particularly difficult to destroy. They resist chemotherapy, allowing cancer to return.

But scientists say it may be possible to kill those stem cells by attaching a chemo drug to nanodiamonds.
Nanodiamonds found to kill cancer stem cells.
They tested this idea using the commonly used chemo drug Epirubicin, which they attached to nanodiamonds, carbon structures with a diameter of about five nanometers, to develop a nanodiamond-Epirubicin drug delivery complex (EPND).

The researchers found that while both standard Epirubicin as well as EPND were capable of killing normal cancer cells, only EPND was capable of killing chemoresistant cancer stem cells and preventing secondary tumor formation in xenograft models of liver cancer.

The study was published in ACS Nano and led by Edward Chow, assistant professor at the National University of Singapore.

Compared to other approaches, delivery of existing chemotherapy drugs with nanomaterials provide a broader range of protection in a package that is both safer and more effective.

The findings show that delivery of Epirubicin by nanodiamonds resulted in a normally lethal dosage of Epirubicin becoming a safe and effective dosage.

As such, delivery of chemotherapy drugs by nanodiamonds not only enables enhanced killing of chemoresistant cancer stem cells, but may be a useful alternative for patients who cannot tolerate the toxic side effects of standard chemotherapy drugs.

Researchers say this approach is not limited to liver cancer and could potentially treat other cancers driven by resistant stem cells.

Source: National University of Singapore
About the Author
  • Will Hector practices psychotherapy at Heart in Balance Counseling Center in Oakland, California. He has substantial training in Attachment Theory, Hakomi Body-Centered Psychotherapy, Psycho-Physical Therapy, and Formative Psychology. To learn more about his practice, click here: http://www.heartinbalancetherapy.com/will-hector.html
You May Also Like
JUN 19, 2018
Cancer
JUN 19, 2018
Cancer-Related Cognitive Impairment aka "ChemoBrain" Needs YOU!
There is a need for neuroscientists to investigate what is known as chemobrain; survivors and providers are looking for ideas for approaches to mitigating this late effect chemo related issue...
JUL 10, 2018
Cancer
JUL 10, 2018
TdT Positive Cells - Not Just for Neoplasms
TdT positive cells are associated with early lymphoid neoplasms but healthy lymphoid precursors can also be positive, especially in pediatric patient lymph nodes....
JUL 17, 2018
Cell & Molecular Biology
JUL 17, 2018
A New Player in the Control of Cell Division
Oil and water don't mix; cells can take advantage of that phenomenon, phase separation, to organize stuff without using membranes...
JUL 17, 2018
Cancer
JUL 17, 2018
Experimental "Trojan Horse" Tumor Destruction Approach Using CRISPR
CRISPR can be used to dupe circulating tumor cells into killing their own main tumor after "re-homing" back with a death receptor for tumor destruction....
JUL 26, 2018
Genetics & Genomics
JUL 26, 2018
When a Cancer Gene Switches Sides
All cells carry a gene named p53, which has a vital role in shielding the body from cancer. But it can betray cells too....
AUG 07, 2018
Cancer
AUG 07, 2018
Potential Bcl-2 Targeted Therapy for Relapsed Multiple Myeloma Patients
Targeted therapy for Bcl-2 may be helpful in more than the two lymphoma diagnoses that were recently approved by the FDA....
Loading Comments...